Conducting research for next-generation regenerative medicine at our own culturing and processing facility
Opening the door to a wide range of therapies with endogenous biological microparticles (EBMs) of mesenchymal stem cells
Striving to establish a regenerative medicine platform using state-of-the-art technology
Maximizing the potential of human adipose-derived stem cells with accumulated technology and excellent know-how
A project for realizing tailored regenerative medicine required to conduct state-of-the-art research

REFERENCE

REFERENCES

Important publications regarding AinproseTM

references

CORPORATION

CORPORATE INFORMATION

We contribute to the implementation of stem cells in treatment through business collaboration.
The field of stem cell research requires steady results, including application to endogenous biological microparticles (EBMs). We contribute to joint research development as well as manufacturing.

CORPORATE INFORMATION